Agenda Profile: Urve Tiidus
First Reading of the Draft Act on Amendments to the Medicines Act (Bill 162 SE)
2024-01-23
15th Riigikogu, 3rd sitting, plenary session
Political Position
The political focus is currently on regulating the safety of pharmaceuticals and vaccines. The speaker raises concerns about the lack of clinical testing for existing vaccines, specifically regarding cancer risk and potential genetic damage. They propose stricter testing requirements for future vaccines, emphasizing a policy-driven and safety-first approach.
1 Speeches Analyzed
Topic Expertise
The speaker addresses specific medical and regulatory issues, such as the clinical testing of vaccines for cancer risk and genetic damage. However, they simultaneously admit that they are not a medical professional, citing the complexity of the subject and their limited professional competence. They rely on the knowledge of the presenter, who is an expert in the medical field.
1 Speeches Analyzed
Rhetorical Style
The style is formal and interrogative, beginning with a respectful address to the chair and the presenter. The speaker employs a rhetorical strategy by acknowledging the presenter's long-standing medical expertise in order to pose a technical and critical question. The tone is cautious, also including a self-critical remark regarding the complexity of the topic.
1 Speeches Analyzed
Activity Patterns
There is not enough data.
1 Speeches Analyzed
Opposition Stance
There is not enough data.
1 Speeches Analyzed
Collaboration Style
The speaker addresses the presenter respectfully and acknowledges their long-standing professional expertise, which indicates a willingness to cooperate with experts. He/She poses a question that seeks solutions to future regulatory problems, demonstrating a constructive approach.
1 Speeches Analyzed
Regional Focus
There is not enough data.
1 Speeches Analyzed
Economic Views
There is not enough data.
1 Speeches Analyzed
Social Issues
Social topics covered include public health and the safety of medical interventions, stressing the necessity for more rigorous clinical testing. The focus is placed on regulatory standards and the mitigation of health risks for citizens.
1 Speeches Analyzed
Legislative Focus
The legislative focus is on the draft Act amending the Medicinal Products Act (Bill 162 SE). The speaker is actively participating in the first reading, posing questions regarding vaccine testing standards and regulatory gaps.
1 Speeches Analyzed